# Damien Leonard

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/damien-leonard
Canonical HTML page: https://getbiobrief.com/entity/damien-leonard

## Timeline

- **2026-03-04**: Financial Disclosure — ImmuCell releases unaudited FY2025 results; Pinetree Capital releases audited results.
- **2026-02-18**: Technical Breakout — ICCC stock price crosses above the 200-day moving average.
- **2025-12-31**: Fiscal Year End — ImmuCell concludes its 2025 fiscal year operations.

## Recent coverage (1 stories)

### ImmuCell FY 2025 Results Highlight Growth in Bovine Health Sector
2026-03-04 23:40:59 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

ImmuCell (ICCC) reported its unaudited financial results for the full year 2025, reflecting a period of manufacturing expansion and sustained demand for its FirstDefense product line. Concurrently, major investor Pinetree Capital Ltd. announced its own audited results and a new director appointment, signaling continued strategic oversight of its animal health portfolio.
Full story: https://getbiobrief.com/story/immucell-fy-2025-financial-results-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.